Earlier Interferon Reduces Disability in Patients With Multiple Sclerosis

Earlier Interferon Reduces Disability in Patients With Multiple Sclerosis

0:00
15 August 2007

Ludwig Kappos REFERENCE: Lancet 2007; 370: 389-97 LUDWIG KAPPOS, University Hospital, Basel Earlier treatment can reduce the risk of confirmed disability in patients with multiple sclerosis, according

Ludwig Kappos

Ludwig Kappos

REFERENCE: Lancet 2007; 370: 389-97LUDWIG KAPPOS, University Hospital, BaselEarlier treatment can reduce the risk of confirmed disability in patients with multiple sclerosis, according to a new study published in the Lancet. Three-year follow-up of the BENEFIT study showed favourable results among patients who began treatment with interferon beta-1b after a first event suggestive of multiple sclerosis, rather than waiting for further confirmatory events. Nicola Solomon interviewedLudwig Kappos.